Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial

BACKGROUND: Economic evaluations commonly accompany trials of new treatments or interventions; however, regression methods and their corresponding advantages for the analysis of cost-effectiveness data are not widely appreciated. METHODS: To illustrate regression-based economic evaluation, we review...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoch, Jeffrey S., Hay, Annette, Isaranuwatchai, Wanrudee, Thavorn, Kednapa, Leighl, Natasha B., Tu, Dongsheng, Trenaman, Logan, Dewa, Carolyn S., O’Callaghan, Chris, Pater, Joseph, Jonker, Derek, Chen, Bingshu E., Mittmann, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555934/
https://www.ncbi.nlm.nih.gov/pubmed/31174497
http://dx.doi.org/10.1186/s12885-019-5779-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555934/
https://www.ncbi.nlm.nih.gov/pubmed/31174497
http://dx.doi.org/10.1186/s12885-019-5779-x

Ejemplares similares